Transmedics Group Inc (TMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 173,933 | 160,764 | 143,823 | 157,370 | 143,537 |
| Cost of Goods | 72,772 | 67,350 | 59,248 | 60,781 | 55,309 |
| Gross Profit | 101,161 | 93,414 | 84,575 | 96,589 | 88,228 |
| Operating Expenses | 88,636 | 72,491 | 61,523 | 60,803 | 61,094 |
| Operating Income | 13,297 | 21,273 | 23,300 | 36,567 | 27,443 |
| Interest Expense | 7,170 | 3,354 | 3,491 | 3,476 | 3,461 |
| Other Income | 2,358 | 3,714 | 3,222 | 3,091 | 2,694 |
| Pre-tax Income | 8,485 | 21,633 | 23,031 | 36,182 | 26,676 |
| Income Tax | 1,170 | -83,750 | -1,288 | 1,275 | 994 |
| Net Income Continuous | 7,315 | 105,383 | 24,319 | 34,907 | 25,682 |
| Net Income | $7,315 | $105,383 | $24,319 | $34,907 | $25,682 |
| EPS Basic Total Ops | 0.21 | 3.10 | 0.71 | 1.03 | 0.76 |
| EPS Basic Continuous Ops | 0.21 | 3.09 | 0.71 | 1.03 | 0.76 |
| EPS Diluted Total Ops | 0.20 | 2.59 | 0.66 | 0.92 | 0.70 |
| EPS Diluted Continuous Ops | 0.20 | 2.59 | 0.60 | 0.86 | 0.64 |
| EPS Diluted Before Non-Recurring Items | 0.30 | 0.57 | 0.66 | 0.92 | 0.70 |
| EBITDA(a) | $25,161 | $28,741 | $30,149 | $43,298 | $33,580 |